JUBILANT INGREVIA - Positional Study

About:
Jubilant Ingrevia was Demerged from Jubilant Lifesciences in February 2021. It is in the business of Speciality chemicals, Animal & human nutrition, life science chemicals, ethanol etc.

- Stock is in a continuous uptrend.
- Price today crossed the previous swing high after forming a base at Support Level (which was earlier a resistance)
- Price broke out with good volumes with good accumulation activity at the end of July.
- Spread chart also gave a breakout of the previous swing high.

Financial Results:
- Jubilant's QoQ Sales growth is 67%
- QoQ Profit growth is 211%

Jubilant Ingrevia is looking financially & technically sound. It looks good for positional investment.